Stockscreener 앱 받기
4.4253
0.32%
0.0153
Cytek Biosciences Inc 주식(CTKB)의 최신 뉴스
Royce & Associates LP Increases Holdings in Cytek Biosciences, Inc. $CTKB - MarketBeat
CTKB SEC FilingsCytek Biosciences, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Cytek Biosciences at TD Cowen Health Care: Strategic Growth Insights By Investing.com - Investing.com Canada
CTKB Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Webinar explores cell sorting breakthroughs, Cytek Biosciences outlines - Traders Union
Cytek Biosciences, Inc. (NASDAQ:CTKB) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
Cytek Biosciences, Inc. (NASDAQ:CTKB) Q4 2025 Earnings Call Transcript - Insider Monkey
Cytek Biosciences (NASDAQ:CTKB) Announces Quarterly Earnings Results, Misses Estimates By $0.36 EPS - MarketBeat
Cytek (CTKB) Q4 2025 Earnings Call Transcript - AOL.com
Cytek Biosciences, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Cytek Biosciences, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:CTKB) 2026-02-27 - Seeking Alpha
Cytek Biosciences (CTKB) Q4 EPS Swing To Loss Reinforces Margin Concerns - Sahm
Cytek Biosciences earnings missed by $0.32, revenue topped estimates - Investing.com Canada
Cytek Biosciences Q4 Earnings Call Highlights - Yahoo Finance
Earnings Call Summary | Cytek Biosciences(CTKB.US) Q4 2025 Earnings Conference - 富途牛牛
Cytek Biosciences, Inc. (CTKB) Reports Q4 Loss, Tops Revenue Estimates - Nasdaq
Earnings call transcript: Cytek Biosciences Q4 2025 sees record revenue, EPS miss - Investing.com Australia
Cytek Biosciences Inc. (CTKB) Stock Falls on Q4 2025 Earnings - Quiver Quantitative
Cytek Biosciences (CTKB) swings to deeper 2025 loss with soft 2026 growth outlook - Stock Titan
Cytek Biosciences, Inc. Provides Revenue Guidance for the Full Year 2026 - marketscreener.com
Cytek Biosciences, Inc. (CTKB) Stock Analysis: Exploring a Potential 37% Upside Amid Challenging Valuations - DirectorsTalk Interviews
Aug Chart Watch: Is Cytek Biosciences Inc stock overvalued or fairly priced2025 Pullback Review & Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Cytek Biosciences (CTKB) CTO exercises RSUs and surrenders shares for tax - Stock Titan
Cytek Biosciences (CTKB) Expected to Announce Earnings on Thursday - Defense World
Cytek Biosciences, Inc. (CTKB) Stock Analysis: Exploring a 42.86% Potential Upside in the Cell Analysis Solutions Market - DirectorsTalk Interviews
Cytek Biosciences to participate at the TD Cowen 46th Annual Health Care Conference - The Manila Times
Live March 4 Cytek Biosciences talk at TD Cowen health care conference - Stock Titan
CTKB Should I Buy - Intellectia AI
Cytek Biosciences, Inc.'s (NASDAQ:CTKB) Share Price Is Still Matching Investor Opinion Despite 27% Slump - simplywall.st
Cytek Biosciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 - marketscreener.com
Cytek Biosciences, Inc. (CTKB): Investor Outlook On A Promising 37.61% Upside Potential - DirectorsTalk Interviews
Is Cytek Biosciences Inc. in a long term uptrendJuly 2025 Weekly Recap & Long Hold Capital Preservation Plans - mfd.ru
Cytek Biosciences Stock (CTKB) Opinions on Preliminary Q4 and FY2025 Revenue Results - Quiver Quantitative
What are Cytek Biosciences Inc.’s technical support levels2025 Investor Takeaways & Expert Curated Trade Setup Alerts - mfd.ru
Can Cytek Biosciences Inc. stock hit analyst price targets2025 Market WrapUp & Real-Time Buy Signal Alerts - mfd.ru
New York State Common Retirement Fund Has $1.15 Million Holdings in Cytek Biosciences, Inc. $CTKB - MarketBeat
Why Cytek Biosciences Inc. stock is trending among retail tradersPortfolio Update Summary & AI Enhanced Market Trend Forecasts - mfd.ru
What You Can Learn From Cytek Biosciences, Inc.'s (NASDAQ:CTKB) P/S - 富途牛牛
Cytek Biosciences, Inc. (NASDAQ:CTKB) Given Consensus Rating of "Hold" by Analysts - MarketBeat
Brown Capital Management LLC Has $17.20 Million Position in Cytek Biosciences, Inc. $CTKB - MarketBeat
Cytek Biosciences (NASDAQ:CTKB) Trading Up 3.2%Should You Buy? - MarketBeat
Cytek Biosciences (NASDAQ:CTKB) Trading Up 3.2% – Should You Buy? - Defense World
Market Outlook: Does Cytek Biosciences Inc stock benefit from AI growthEarnings Recap Report & Technical Buy Zone Confirmations - baoquankhu1.vn
This Cytek Biosciences Insider Increased Their Holding By 169% Last Year - Yahoo Finance
Cytek Biosciences, Inc. (CTKB) Investor Outlook: Navigating the Healthcare Sector with a 17% Potential Upside - DirectorsTalk Interviews
Cytek Biosciences Data Breach Investigation - Strauss Borrelli PLLC
Aug Closing: Is Cytek Biosciences Inc stock overvalued or fairly priced2025 Major Catalysts & Technical Buy Zone Confirmations - baoquankhu1.vn
Cytek Biosciences, Inc. (CTKB) Investor Outlook: Analyzing The 8.70% Potential Upside - DirectorsTalk Interviews
Institutional owners may take dramatic actions as Cytek Biosciences, Inc.'s (NASDAQ:CTKB) recent 6.9% drop adds to one-year losses - simplywall.st
Why Cytek Biosciences Inc. (8EQ) stock attracts HNW investorsJuly 2025 Big Picture & High Conviction Investment Ideas - bollywoodhelpline.com
CYTEK BIOSCIENCES Q4 2025 Earnings Preview: Recent $CTKB Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative
Cytek Biosciences (NASDAQ:CTKB) Shares Up 8.2%Here's What Happened - MarketBeat
Cytek Biosciences, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year 2025 - marketscreener.com
Cytek Biosciences, Inc. (NASDAQ:CTKB) Receives Average Rating of “Hold” from Analysts - Defense World
Cytek Biosciences Preliminary Q4 Revenue Up 8% - Nasdaq
Cytek Biosciences Reports Preliminary Revenue of Approximately $201 Million for Full Year 2025 - Quiver Quantitative
Cytek Biosciences Announces Preliminary Fourth Quarter and Full Year 2025 Revenue Results - GlobeNewswire
Cytek Biosciences, Inc. (NASDAQ:CTKB) Receives Average Rating of "Hold" from Analysts - MarketBeat
Will Cytek Biosciences Inc. (8EQ) stock top growth indexesWeekly Profit Report & High Accuracy Trade Signal Alerts - ulpravda.ru
Why Cytek Biosciences Inc. stock is a must watch in 20252025 Pullback Review & Community Consensus Trade Signals - Улправда
Is Cytek Biosciences Inc. stock attractive for retirement portfoliosRisk Management & Technical Confirmation Trade Alerts - Улправда
What analyst consensus implies for Cytek Biosciences Inc. (8EQ) stockBond Market & Weekly High Return Forecasts - Улправда
1.81%
자본화:
|
볼륨(24시간):